Jennison Associates’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,387,919
| Closed | -$63.9M | – | 820 |
|
|
2016
Q3 | $63.9M | Sell |
1,387,919
-436,250
| -24% | -$20.1M | 0.07% | 244 |
|
|
2016
Q2 | $91.6M | Sell |
1,824,169
-6,085
| -0.3% | -$306K | 0.1% | 177 |
|
|
2016
Q1 | $97.9M | Buy |
1,830,254
+25,299
| +1% | +$1.35M | 0.1% | 172 |
|
|
2015
Q4 | $118M | Sell |
1,804,955
-104,505
| -5% | -$6.86M | 0.12% | 149 |
|
|
2015
Q3 | $108M | Buy |
1,909,460
+162,612
| +9% | +$9.18M | 0.11% | 167 |
|
|
2015
Q2 | $103M | Sell |
1,746,848
-343,225
| -16% | -$20.3M | 0.09% | 197 |
|
|
2015
Q1 | $130M | Buy |
2,090,073
+172,793
| +9% | +$10.8M | 0.12% | 163 |
|
|
2014
Q4 | $110M | Sell |
1,917,280
-197,372
| -9% | -$11.4M | 0.1% | 189 |
|
|
2014
Q3 | $114M | Sell |
2,114,652
-1,807,533
| -46% | -$97.2M | 0.11% | 177 |
|
|
2014
Q2 | $206M | Buy |
3,922,185
+193,895
| +5% | +$10.2M | 0.19% | 112 |
|
|
2014
Q1 | $197M | Buy |
3,728,290
+2,699,462
| +262% | +$143M | 0.19% | 111 |
|
|
2013
Q4 | $41.2M | Sell |
1,028,828
-4,106
| -0.4% | -$165K | 0.04% | 345 |
|
|
2013
Q3 | $39M | Sell |
1,032,934
-3,264
| -0.3% | -$123K | 0.04% | 345 |
|
|
2013
Q2 | $40.6M | Buy |
+1,036,198
| New | +$40.6M | 0.05% | 320 |
|